Dimitrios Daoussis

Summary

Publications

  1. ncbi Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis
    Dimitrios Daoussis
    Consultant Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 39:369-83. 2010
  2. ncbi Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis
    Dimitrios Daoussis
    Department of Internal Medicine, Division of Rheumatology, Patras University Hospital, University of Patras, Patras, Greece
    Arthritis Rheum 62:150-8. 2010
  3. ncbi Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, 26504 Rion, Patras, Greece
    Rheumatology (Oxford) 49:271-80. 2010
  4. ncbi Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, UK
    Arthritis Res Ther 11:R116. 2009
  5. ncbi Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 40:127-36. 2010
  6. ncbi The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 41:170-7. 2011
  7. ncbi Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, 26504, Rion, Patras, Greece
    Rheumatol Int 31:841-2. 2011
  8. ncbi Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, UK
    Clin Rheumatol 30:477-84. 2011
  9. ncbi B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras, Greece
    Int J Rheumatol 2011:214013. 2011
  10. ncbi Bony ears
    Dimitrios Daoussis
    University of Patras Medical School, Patras University Hospital, Patras, Greece
    Arthritis Rheum 58:611. 2008

Detail Information

Publications10

  1. ncbi Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis
    Dimitrios Daoussis
    Consultant Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 39:369-83. 2010
    ..This review focuses on the recent information about the pathophysiology of the Wingless (Wnt) pathway and interleukin-17 (IL-17) in relation of their role in bone and joint remodeling...
  2. ncbi Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis
    Dimitrios Daoussis
    Department of Internal Medicine, Division of Rheumatology, Patras University Hospital, University of Patras, Patras, Greece
    Arthritis Rheum 62:150-8. 2010
    ..Dkk-1 is an inhibitory molecule that regulates the Wnt pathway, which controls osteoblastogenesis. This study was undertaken to explore the potential role of Dkk-1 in ankylosing spondylitis (AS), a prototypical bone-forming disease...
  3. ncbi Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, 26504 Rion, Patras, Greece
    Rheumatology (Oxford) 49:271-80. 2010
    ..To assess the efficacy of rituximab (RTX) in SSc...
  4. ncbi Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, UK
    Arthritis Res Ther 11:R116. 2009
    ..In this study we investigated whether UA associates with renal dysfunction in patients with RA and whether such an association is independent or mediated through other comorbidities or risk factors for renal impairment...
  5. ncbi Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 40:127-36. 2010
    ....
  6. ncbi The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece
    Semin Arthritis Rheum 41:170-7. 2011
    ..Dickkopf-1 (DKK-1), an inhibitor of the Wnt pathway, has recently emerged as an important player in several critical aspects of bone biology...
  7. ncbi Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, 26504, Rion, Patras, Greece
    Rheumatol Int 31:841-2. 2011
    ..Clinical studies as well have provided preliminary data pointing to the direction that B-cell depletion with rituximab might be a therapeutic option for patients with this debilitating disease...
  8. ncbi Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation
    Dimitrios Daoussis
    Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Pensnett Road, Dudley, West Midlands, DY1 2HQ, UK
    Clin Rheumatol 30:477-84. 2011
    ..Given the association of MA with MetS, future prospective studies are needed to establish the use of MA as a screening tool for RA patients at increased CVD risk...
  9. ncbi B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence
    Dimitrios Daoussis
    Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras, Greece
    Int J Rheumatol 2011:214013. 2011
    ..Definite conclusions regarding the clinical efficacy of RTX in SSc cannot be drawn but further exploration with a multicenter, randomized study is warranted...
  10. ncbi Bony ears
    Dimitrios Daoussis
    University of Patras Medical School, Patras University Hospital, Patras, Greece
    Arthritis Rheum 58:611. 2008